Skip to main content

Advertisement

SpringerLink
Log in

Effects of Bone Marrow Mesenchymal Stem Cells on Hematopoietic Recovery and Acute Graft-Versus-Host Disease in Murine Allogeneic Umbilical Cord Blood Transplantation Model

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

To investigate the effect of bone marrow mesenchymal stem cells (MSC) on hematopoietic recovery and acute graft-versus-host disease (GVHD) in a murine allogeneic umbilical cord blood transplantation (allo-UCBT) model. MSCs were obtained from C57/BL mouse bone marrow. The MSC phenotypes were identified by flow cytometry (FCM), and their ability to differentiate into osteoblasts and adipocytes was tested. Once murine allo-UCBT and aGVHD models were established, mice were divided into five groups: (1) total body irradiation (TBI) group, each mouse receiving 0.3 ml sterile saline infusion after TBI and used as control; (2) UCB group, receiving 2 × 106 umbilical cord blood mononuclear cells (UCB-MNC) after TBI; (3) UCB+MSC group, receiving 2 × 106 UCB-MNC and 2 × 107 MSC after TBI; (4) UCB+SC group, receiving 2 × 106 UCB-MNC and 2 × 106 spleen cells after TBI; and (5) UCB+SC+MSC group, receiving 2 × 106 UCB-MNC, 2 × 107 MSC and 2 × 106 spleen cells after TBI. To evaluate the engraftment of HSC, the white blood cells, red blood cells, and platelets counts were tested at different time points after transplantation, and the ratio of chimerism was identified by FCM. The acute GVHD clinical scores, recipient mice survival, and the histopathological analyses were used to evaluate the effect of MSC on acute GVHD. MSCs were successfully obtained in vitro and FCM analysis showed that these cells are highly positive for CD90.2, CD44, and negative for CD34, CD45, and they are capable to differentiate into osteoblasts and adipocytes after being induced. Compared to UCB group, the UCB+MSC mice had shorter duration of myelosuppression and higher percentage of donor-derived cells which was up to 22.87 ± 4.3 % and the white blood cell (WBC), red blood cell (RBC), and platelet counts started to increase by day 6 after transplantation. Moreover, the average survival time for UCB+MSC mice was 25.0 ± 10.55 days, while for the UCB group it was 15.5 ± 12.50 days. The UCB+SC mice showed fatigue, loss of appetite, weight loss, arched back, and hair ruffling on day 13 post transplantation. Approximately 50 % of mice showed skin ulcers, had diarrhea and other manifestations of acute GVHD, and all mice were died within 20 days. Histopathological analysis confirmed grade II–IV GVHD manifestation. In addition to transient weight loss, some UCB+SC+MSC mice developed arched back, hair ruffling, diarrhea and other manifestations of acute GVHD. The clinical scores in UCB+SC+MSC mice with acute GVHD (grade I–II or without GVHD) were lower than UCB+SC group (P < 0.05). Bone marrow MSCs can promote hematopoietic recovery and decrease the incidence of acute GVHD in murine allo-UCBT model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Gluckman, E., & Rocha, V. (2009). Cord blood transplantation: State of the art. Haematologica, 94, 451–454.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Frassoni, F., Gualandi, F., Podestà, M., et al. (2008). Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: A phase I/II study. The Lancet Oncology, 9, 812–814.

    Article  Google Scholar 

  3. Szabolcs, P., & Niedzwiecki, D. (2008). Immune reconstitution in children after unrelated cord blood transplantation. Biology of Blood and Marrow Transplantation, 14(1 suppl 1), 66–72.

    Article  PubMed  Google Scholar 

  4. Komanduri, K. V., John, L. S., de Lima, M., et al. (2007). Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood, 110(13), 4543–4551.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Takami, A., Mochizuki, K., Asakura, H., et al. (2005). High incidence of cytomegalovirus reactivation in adult recipients of an unrelated cord blood transplant. Haematologica, 90(9), 1290–1292.

    PubMed  Google Scholar 

  6. Kurtzberg, J., Prasad, V. K., Carter, S. L., et al. (2008). Results of the cord blood transplantation study (COBLT): Clinical outcome of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood, 112(10), 4318–4327.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Gluckman, E. (2000). Current status of umbilical cord blood hematopoietic stem cell transplantation. Experimental Hematology, 28(11), 1197–1205.

    Article  CAS  PubMed  Google Scholar 

  8. Marktel, S., Magnani, Z., Cicer, F., et al. (2003). Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation. Blood, 101(4), 1290–1298.

    Article  CAS  PubMed  Google Scholar 

  9. Cohen, J. L., Boyer, O., Thomas-Vaslin, V., et al. (1999). Suicide gene-mediated modulation of GVHD. Leukaemia & Lymphoma, 34(5–6), 473–480.

    CAS  Google Scholar 

  10. Peister, A., Mellad, J. A., Larson, B. L., et al. (2004). Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood, 103, 1662–1668.

    Article  CAS  PubMed  Google Scholar 

  11. Cooke, K. R., Kobzik, L., Martin, T. R., et al. (1996). An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood, 88, 3230–3239.

    CAS  PubMed  Google Scholar 

  12. Jiang, X. X., Zhang, Y., Liu, B., et al. (2005). Human mesenchymal stem cells inhibit differentiation and function of monocyte derived dendritic cells. Blood, 105(10), 4120–4126.

    Article  CAS  PubMed  Google Scholar 

  13. Di Nicola, M., Carlo-Stella, C., Magni, M., et al. (2002). Human bone marrow stormal cells suppress T lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99(10), 3838–3843.

    Article  PubMed  Google Scholar 

  14. Krampera, M., Cosmi, L., Angeli, R., et al. (2006). Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells, 24, 386–398.

    Article  CAS  PubMed  Google Scholar 

  15. Sudres, M., Norol, F., & Trenado, A. (2006). Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. Journal of Immunology, 176, 7761–7767.

    Article  CAS  Google Scholar 

  16. Bernardo, M. E., Ball, L. M., & Cometa, A. M. (2011). Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation. Bone Marrow Transplantation, 46, 200–207.

    Article  CAS  PubMed  Google Scholar 

  17. Meuleman, N., Tondreau, T., & Ahmad, I. (2009). Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: A pilot study. Stem Cells and Development, 18, 1247–1252.

    Article  PubMed  Google Scholar 

  18. Ringdén, O. (2009). Mesenchymal stromal cells as first-line treatment of graft failure after hematopoietic stem cell transplantation. Stem Cells and Development, 18, 1243–1246.

    Article  PubMed  Google Scholar 

  19. Kim, D. H., Yoo, K. H., Yim, Y. S., et al. (2006). Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice. Journal of Korean Medical Science, 21, 1000–1004.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Joo, S. Y., Cho, K. A., Jung, Y. J., et al. (2010). Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner. Cytotherapy, 12, 361–370.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, The Affiliated Hospital of Xuzhou Medical College, Xuzhou, 221002, China

    Zhen Yu Li, Chun Qing Wang, Guang Lu, Xiu Ying Pan & Kai Lin Xu

Authors
  1. Zhen Yu Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chun Qing Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guang Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiu Ying Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kai Lin Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kai Lin Xu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Z.Y., Wang, C.Q., Lu, G. et al. Effects of Bone Marrow Mesenchymal Stem Cells on Hematopoietic Recovery and Acute Graft-Versus-Host Disease in Murine Allogeneic Umbilical Cord Blood Transplantation Model. Cell Biochem Biophys 70, 115–122 (2014). https://doi.org/10.1007/s12013-014-9866-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-014-9866-y

Keywords

Search

Navigation